CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,138,950
- in 5 filings, $4.8M under 10b5-1 plans
Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-23 | Radovich Peter PRESIDENT AND COO | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2024-01-23 | Radovich Peter PRESIDENT AND COO | Grant or award · Restricted Stock Units | +17,250 | 17,250 | ||
| 2024-01-23 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-23 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +37,500 | 37,500 | ||
| 2024-01-16 | Quan Joanne CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2024-01-16 | Quan Joanne CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +37,500 | 37,500 | ||
| 2024-01-08 | Radovich Peter CHIEF OPERATING OFFICER | Sale | −1,408 | $28.03 | $39K | 36,485 |
| 2024-01-08 | Longpre Lara CHIEF DEVELOPMENT OFFICER | Sale | −1,019 | $28.04 | $29K | 105,254 |
| 2024-01-08 | Vig Pamela HEAD OF RESEARCH & DEVELOPMENT | Sale | −1,408 | $28.03 | $39K | 29,905 |
| 2024-01-08 | Peetz Christopher PRESIDENT AND CEO | Sale | −5,209 | $28.03 | $146K | 110,125 |
| 2024-01-08 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | −528 | $28.04 | $15K | 722 |
| 2024-01-06 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise | +1,250 | 1,250 | ||
| 2024-01-06 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise · Restricted Stock Units | −1,250 | 1,250 | ||
| 2023-12-05 | Howe Jolanda SVP, Global Controller | Option exercise | +2,500 | $2.94 | $7K | 2,500 |
| 2023-12-05 | Howe Jolanda SVP, Global Controller | Sale | −2,500 | $32.40 | $81K | 0 |
| 2023-12-05 | Howe Jolanda SVP, Global Controller | Option exercise · Stock Option (right to buy) | −2,500 | 55,400 | ||
| 2023-11-10 | Vig Pamela Head of Research & Development | Grant or award | +527 | $22.29 | $12K | 31,313 |
| 2023-11-10 | Longpre Lara Chief Development Officer | Grant or award | +434 | $22.29 | $10K | 106,273 |
| 2023-11-10 | Radovich Peter Chief Operating Officer | Grant or award | +218 | $22.29 | $5K | 37,893 |
| 2023-11-09 | Heron Patrick J Director | Purchase | +2,910 | $28.30 | $82K | 161,963 |
Page 20 of 25 · 490 trades